Comparing Biktarvy vs Symtuza
| Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) |
|
|---|
| Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
Prescription only
Prescribed for HIV Infection. Symtuza may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | More about Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Biktarvy has an average rating of 7.2 out of 10 from a total of 226 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 19% reported a negative effect. |
Symtuza has an average rating of 8.3 out of 10 from a total of 9 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 11% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Biktarvy side effects |
View all Symtuza side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Biktarvy prices |
View all Symtuza prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
180 hours |
180 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 446 drugs are known to interact with Biktarvy:
|
A total of 780 drugs are known to interact with Symtuza:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 07, 2018 |
July 17, 2018 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.